Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Aquaporin water channels in the nervous system.
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Acute Disseminated Encephalomyelitis.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
Risk factors for idiopathic optic neuritis recurrence.
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
Preliminary results after upper cervical chiropractic care in patients with chronic cerebro-spinal venous insufficiency and multiple sclerosis.
Atypical Optic Neuritis.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.
Another promising oral agent for multiple sclerosis.
Microcystic macular oedema confirmed, but not specific for multiple sclerosis.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Evoked potential tests in clinical diagnosis.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
[Current state of research on multiple sclerosis].
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis.
Pain-related mood influences pain perception differently in fibromyalgia and multiple sclerosis.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
The formation of inflammatory demyelinated lesions in cerebral white matter.

Pages